Kymera Therapeutics, Inc. - COM (KYMR)

Historical Portfolio Holders from Q3 2020 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
67 M
Holdings value Q1 2024
$2.69 B
Value change Q1 2024
+$300 M
Grand Portfolio weight change Q1 2024
+0.001%
Number of holders
155
Number of buys Q1 2024
2
Number of sells Q1 2024
-1
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
501575104
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 42 K $1.25 M -$99.9 K $29.85 3
2024 Q1 67.1 M $2.7 B +$300 M $40.20 157
2023 Q4 60.4 M $1.54 B +$91.9 M $25.46 133
2023 Q3 57.2 M $795 M -$17.4 M $13.90 118
2023 Q2 58 M $1.33 B +$24.1 M $22.99 121
2023 Q1 56.8 M $1.68 B +$23.1 M $29.63 124
2022 Q4 56.1 M $1.4 B +$98.6 M $24.96 117
2022 Q3 52 M $1.13 B +$28.5 M $21.77 116
2022 Q2 49.2 M $969 M +$11.6 M $19.69 98
2022 Q1 45.3 M $1.92 B +$62.3 M $42.32 125
2021 Q4 43.1 M $2.74 B +$117 M $63.49 124
2021 Q3 34.2 M $2.01 B +$485 M $58.74 112
2021 Q2 26.5 M $1.29 B +$190 M $48.50 110
2021 Q1 22.8 M $887 M +$90.2 M $38.86 94
2020 Q4 20.3 M $1.25 B +$42.7 M $62.00 74
2020 Q3 16.4 M $527 M +$527 M $32.31 50